Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy Study of Oral Monepantel in Individuals With Motor Neurone Disease

NCT04894240 is registered in ClinicalTrials.gov with Neurizon Therapeutics Limited as lead sponsor.

NCT NCT04894240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04894240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy Study of Oral Monepantel in Individuals With Motor Neurone Disease
Lead sponsor
Neurizon Therapeutics Limited
Phase
Phase 1
Overall status
Completed
Start date
June 28, 2022
Completion date
November 29, 2023
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

motor neuron disease